1. 275PEfficacy and tolerability of olaparib in Asian patients with recurrent ovarian, primary peritoneal or fallopian tube carcinoma: The National University Cancer Institute, Singapore experience. (25th November 2018) Authors: Heong, V Y M; Lim, Y W; Lee, S C; Ow, S; Lim, S E; Ong, P Y; Low, J; Ng, J; Ilancheran, A; Tong, P; Lim, D; Tan, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Patients with more comorbidities have better detection but poorer management of chronic diseases. (13th November 2019) Authors: Sum, G; Koh, G C H; Mercer, S W; Lim, Y W; Majeed, A; Oldenburg, B; Lee, J T Journal: European journal of public health Issue: Volume 29(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗